On: Bay Area biotech company Synthego, raised $392M, forced into bankruptcy

[duxup]

Biotech seems to historically require a lot of iterations / failures before breakthroughs happen.

I'm not sure the typical VC "startup" type expectations / speed really lends itself to that kind of business.